III.J.19. Medical Countermeasures for Encephalomyelitis Viruses. Develop medical countermeasures against the biological warfare threat of the encephalomyelitis viruses, a group of viruses that cause disorientation, convulsions, paralysis, and death. Vaccines will protect 80 percent of the immunized population against an aerosol exposure of the virus and will induce minimum reactogenicity in soldiers when immunized. By FY96, transition to development an improved vaccine effective against Venezuelan equine encephalomyelitis (VEE) virus stereotypes 1 A/B/C. By FY98, construct analogous vaccines for Eastern equine encephalomyelitis (EEE) and Western equine encephalomyelitis (WEE). By FY00, develop a multivalent VEE vaccine that includes serotypes 1E and III.
Supports: Army Modernization Plan Objectives, Medical Annex OProject, Sustain, and Protect the Force by Development of NBC Agent Preventive Measures. Provides for the exploration, demonstration, and validation of biological defense vaccines as outlined by the DEPSECDEF (26 Aug 91) and the Joint Requirements Oversight Council (31 Aug 92).
|STO Manager:||TSO:||TRADOC POC:|
|Dr. Anna Johnson-Winegar||MAJ Mark Seymour||CPT Ensor|